Bharat Parenterals Quarterly Results for Trading Insights

BPLPHARMA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹-9 Cr
QSept 2025
Quarterly Results

Bharat Parenterals Quarterly Results Key Highlights

  • Revenue of ₹68 Cr in Sept 2025 (-35.8% vs Mar 2025, -10.5% vs Sept 2024)
  • Net Profit of ₹-9 Cr in Sept 2025 (+0.0% vs Mar 2025, +50.0% vs Sept 2024)
  • EBITDA of ₹4 Cr in Sept 2025 (+0.0% vs Mar 2025)
  • Operating Margin of 1.0% in Sept 2025 (-1.0pp vs Mar 2025)
  • Earnings Per Share of ₹-14.00 in Sept 2025 (+2.8% vs Mar 2025)

Bharat Parenterals Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 68 106 117 76 71 -35.8% -10.5%
Net Profit (₹ Cr) -9 -9 -1 -18 -3 - -
EBITDA (₹ Cr) 4 4 15 -4 4 - -
EPS (₹) -14.00 -14.40 -1.00 -27.00 -0.62 - -
Operating Margin (%) 1.0% 2.0% 12.0% -11.0% 1.0% - -

Bharat Parenterals Share Price Trend Around Quarterly Results

Visualize Bharat Parenterals's 1-year price movement across quarterly results — ideal for logging trades in Bharat Parenterals share price chart using Tickjournal. All values in ₹.

Profitability Ratios

Profit Margin -13.2%
EBITDA Margin 5.9%
Operating Margin 1.0%
ROE (Annual) -10.6%

Balance Sheet Highlights

Total Assets ₹649 Cr
Total Equity ₹339 Cr
Current Assets ₹356 Cr
Current Liabilities ₹90 Cr

Cash Flow Analysis

Operating Cash Flow ₹-27 Cr
Investing Cash Flow ₹-137 Cr
Financing Cash Flow ₹156 Cr
Net Cash Flow ₹-8 Cr

Current Market Data

Current Price ₹1110.00
Exchange BSE
Last Updated Mar 05, 2026

Sector Competitors - Quarterly Performance Comparison

Comparing Bharat Parenterals quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹416,764.48 Cr 1784.5 14,875 3,125 +10.8% - 21.0% 137.3
Divis Laboratories
Sept 2025
₹170,125.54 Cr 6364.5 2,860 689 +7.1% - 24.1% 245.1
Torrent Pharmaceuti…
Sept 2025
₹146,658.56 Cr 4353.4 3,219 591 +11.3% - 18.4% 248.2
Cipla
Sept 2025
₹109,178.44 Cr 1326.4 7,716 1,353 +12.0% - 17.5% 79.3
Dr Reddys Laborator…
Sept 2025
₹107,358.50 Cr 1313.5 9,135 1,337 +1.1% - 14.6% 81.2
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores